Patent ID: 11959103
Assignee: KYOTO UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 6:
7. The method according to claim 5, wherein human iPS cells are induced to differentiate into skeletal muscle cells in a culture medium containing basic fibroblast growth factor and hepatocyte growth factor, and wherein cells are brought into contact with a conjugate in which perlecan domain 1 is conjugated to the α chain C-terminus of a human laminin α4β2γ1 E8 fragment, the α chain C-terminus of a human laminin α5β1γ1 E8 fragment, the α chain C-terminus of a human laminin α4β1γ1 E8 fragment, or the α chain C-terminus of a human laminin α5β2γ1 E8 fragment.